ArticleBMC medical informatics and decision making2026
Interpretable machine learning based decision-making system for lung adenocarcinoma metastasis: a population-based study with exploration of multi-classification models.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate metastasis prediction in lung adenocarcinoma is essential for effective treatment plans and improved prognosis. Current methods face challenges in accuracy and clinical application.
methodsWe developed a binary classification model (XGBoost) and a multiclassification model (stacking) using SEER database data. The binary model predicts metastasis presence (M0 vs. non-M0), and the multiclassification model further refines the degree of metastasis (M1a, M1b, M1c). Model performance was assessed using ROC AUC, PR AUC, and KS curves. SHAP values were used to analyze important features and explain the decision-making process.
resultsThe binary model achieved ROC AUC and PR AUC scores exceeding 0.77, with the KS curve showing high consistency in distinguishing between positive and negative samples. The multiclassification model also performed well, demonstrating stability and generalizability across different metastasis stages. Key predictive factors included AJCC stage, survival duration, tumor size, and treatment information.
conclusionThis study improves the accuracy and clinical application of metastasis prediction in lung adenocarcinoma through interpretable machine learning models. The combination of binary and multiclassification models not only predicts metastasis presence but also details its extent, providing valuable clinical decision support. Future research should integrate diverse data sources to enhance model robustness and better serve clinical practice. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.